Sign in

CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
113516358
Phone
(984) 884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
  1. 10QSB Other 10QSB
  2. NT 10-Q Other NT 10-Q
  3. 8-K Event New debt or obligation · Unregistered share sale
  4. 8-K Event Executive or director change
  5. REGDEX Other REGDEX
  6. SC 13D Stake Beneficial Ownership Report
  7. SC 13D Stake Beneficial Ownership Report
  8. SC 13D Stake Beneficial Ownership Report
  9. SC 13D Stake Beneficial Ownership Report
  10. SC 13D Stake Beneficial Ownership Report
  11. SC 13D Stake Beneficial Ownership Report
  12. SC 13D Stake Beneficial Ownership Report
  13. 10QSB Other 10QSB
  14. SC 13D/A Stake Beneficial Ownership Report
  15. SC 13D/A Stake Beneficial Ownership Report
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 51 of 54 · 1,070 filings